PReS-FINAL-2139: Tapering and withdrawal of tocilizumab in patients with systemic JIA in inactive disease: results from an alternative dosing regimen in the tender study

Detalles Bibliográficos
Autores principales: De Benedetti, F, Ruperto, N, Brunner, HI, Grom, A, Wulffraat, N, Henrickson, M, Jerath, R, Kimura, Y, Kadva, AK, Wang, J, Martini, A, Lovell, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042215/
http://dx.doi.org/10.1186/1546-0096-11-S2-P151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042215/
http://dx.doi.org/10.1186/1546-0096-11-S2-P151

Ejemplares similares